1Kovou I, Schmidt T, Bonizzoni E, el al. Incidence. predictors, and outcome of thrombosis after successful implantation of drug - eluting stents[J].J Am Med Assoc,2005.293(17) :2126 - 2130.
2Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug - eluting coronary stents[J]. J Am Coll Cardi ol,2006,47(1) :175 - 181.
3Joner M, Finn AV, Farb A, et al. Pathology of drug - eluting stems in humans: Delayed healing and late thrombotic risk[J].J Am Coll Cardiol,2006,48(1) :193 - 202.
4Alfonso F,Suarez A. Angiolillo DJ, et al. Findings of inlravascular ultrasound during acute stent thrombosis[J]. Heart. 2004,90 (12) 1455 - 1459.
5Park DW,Park SW,Park KH,el al. Frequency of and risk factors for stent thrombosis after drug eluting stent implantation during long-term follow up[J]. AmJ Cardiol,2006,98(3):352-356.
6Moreno R, Fernandez C, Hernandez R.et al. Drug - eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies[J]. J Am Coll Cardiol,2005, {5(6) :954 - 959.
7Smith SC, Feldman TE. Hirshfeld JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:A report of the American College of Cardiology/American Heart Association task force on practice guidelines[J]. Circulation, 2006,113(7) : 166 - 286.
8Fidder GI, Lumley P. Preliminary clinica lstudies with thromboxane synthase inhibitors and thromboxane receptors hlockers[J]. Circulation,1990,81 (Suppl1) :169 - 178.
7Abouchebl A, Reginelli JP, Bajzerc T, et al. Intracranial hemor rhage and hyperperfusion syndrome following carotid artery stent- ing : Risk factors, prevention, and treatment [J]. J Am Coll Cardiol,2004,43(9) :1596 - 1601.
